Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
Endocrine Cancer
ENDOCRINE CANCER ADVISOR
FEATURED CONTENT
-
-
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection. -
First Human Clinical Trial in US to Test the Use of CRISPR-Modified T Cells in Cancer Answers Vital Questions
CRISPR-modified T cells were used in 3 patients with advanced cancer for the first time, showing modest results on tumor growth. -
Evidence Suggests B Cells Play a Role in Immunotherapy Response
New research shows that B cells — and not just T cells — influence whether patients respond to immunotherapy in melanoma, sarcoma, and kidney cancers. -
The Questionable Practice That Permeates Oncology Clinical Trials
Most oncology phase 1 trials use a simplistic, outdated dose-finding technique, and experts agree that change is needed.
ENDOCRINE CANCER NEWS
Aggressive Subtypes of Papillary Thyroid Cancer Deserve Increased Attention
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
Pediatric Thyroid Cancer Rates Are Rising, but Some Experts Doubt the Significance
Factors Associated With Thyroid Cancer Overtreatment Identified
Want to read more?
Please login or register first to view this content.
Next post in Endocrine Cancer
